Inversion of ibuprofen in body helps fight cancer: Study

Singapore: Scientists at the Department of Pharmacy and Pharmacology, University of Bath, UK, demonstrated that anti-inf...

September 30, 2013 | Monday | News
Australia ideal for early-stage drug development

Australia has a long history in biomedical research, with a reputation for excellence and invention since the early 1900...

June 14, 2012 | Thursday | Opinion
HUYA, Sanzao Park partner for drug development

Singapore: HUYA Bioscience, a leader in globalizing China's biopharmaceutical innovations, has signed a strategic partne...

June 11, 2012 | Monday | News
GSK's cancer drug gets EU marketing authorization

Singapore: European Commission has granted an additional indication for GlaxoSmithKline's Tyverb (lapatinib) to be used ...

August 16, 2013 | Friday | Regulatory
Astellas completes patient recruitment in drug trial

Singapore: Japanese company Astellas Pharma has completed patient recruitment for the isavuconazole phase III registrati...

December 19, 2012 | Wednesday | News
Daiichi Sankyo expands drug discovery program

Singapore: Japan-based Daiichi Sankyo has decided to expand its collaborative drug discovery program with universities a...

July 30, 2013 | Tuesday | News
Boehringer terminates insulin deal with Lilly

Singapore: Eli Lilly and Boehringer Ingelheim are making a slight adjustment to their diabetes alliance with respect to...

January 8, 2013 | Tuesday | News
Cellmid gets positive sign with Midkine antibody for kidney disease

Singapore: Australia's Cellmid has completed its first in-life diabetic nephropathy study with anti-midkine antibodies (...

April 24, 2014 | Thursday | News
Takeda Gemini II trial shows positive results

Singapore: Positive results were reported from Takeda Pharmaceutical's international, randomized, placebo-controlled, ...

May 14, 2012 | Monday | News
IOF, Fonterra grants $43K to Indonesian for bone R&D

Singapore: Global organization, International Osteoporosis Foundation (IOF), and New Zealand dairy firm, Fonterra have c...

July 25, 2013 | Thursday | News
Vanda Pharma withdraws application for Fanaptum

Singapore: Vanda Pharmaceuticals has withdrawn its application from European Medicines Agency for a centralized marketin...

March 15, 2013 | Friday | Regulatory
AbbVie invests $320 mn in bilogics manufacturing in Singapore

Singapore: Research based pharmaceutical company, AbbVie, has made investment of around USD320 million in Singapore to s...

April 24, 2014 | Thursday | News
Prana Alzheimer's trial shows +ve results

Singapore: Prana Biotechnology reported on the progress of its lead development asset PBT2, which is in phase II trials ...

April 8, 2013 | Monday | News
Astellas to do interim analysis of cancer trial

Singapore: Medivation and Astellas Pharma have established an updated interim analysis plan for the Prevail trial, a glo...

April 3, 2013 | Wednesday | News
Novartis acquires cancer firm CoStim

Singapore: Global pharmaceutical firm, Novartis, has acquired CoStim Pharmaceuticals, a privately held biotechnology com...

February 18, 2014 | Tuesday | News
Cytos reveals trial data allergic asthma immune modulator

Singapore: Cytos Biotechnology revealed additional results of the phase IIa clinical trial with CYT003, a first-in-class...

September 9, 2013 | Monday | News
Prism to start PRI-724 trials to treat fibrosis

Singapore: Prism Pharma, a drug discovery company focused on developing small molecule technologies that modulate protei...

June 14, 2013 | Friday | News
Boehringer, Eli Lilly reveal post-hoc results for linagliptin

Singapore: Boehringer Ingelheim Pharmaceuticals and Eli Lilly and Company revealed results from a post-hoc analysis, whi...

June 11, 2012 | Monday | News